Anticipatory pleasure skills training: A new intervention to reduce anhedonia in Schizophrenia

Perspectives in Psychiatric Care

Volumn 46, Issue 3, 2010, Pages 171-181

  Favrod, Jérôme ^a,b   Giuliani, Fabienne ^a   Ernst, Fanny ^c   Bonsack, Charles ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF APPLIED SCIENCES WESTERN SWITZERLAND   (Switzerland)

^c Etablissement médico social Le Pré Carré   (Switzerland)

Author keywords

Anhedonia; Anticipatory pleasure; Cognitive therapy; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AGED; APATHY; ARTICLE; COGNITIVE DEFECT; COGNITIVE THERAPY; DAILY LIFE ACTIVITY; EMOTIONAL DISORDER; FEMALE; HUMAN; LEARNING; MALE; METHODOLOGY; MIDDLE AGED; MOTIVATION; MULTIMODALITY CANCER THERAPY; NURSING; PERSONALITY TEST; PILOT STUDY; PLEASURE; PSYCHOLOGICAL ASPECT; PSYCHOLOGY; SCHIZOPHRENIA;

ACTIVITIES OF DAILY LIVING; ADULT; AFFECTIVE SYMPTOMS; AGED; ANTIPSYCHOTIC AGENTS; APATHY; COGNITION DISORDERS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTIVATION; PERSONALITY INVENTORY; PILOT PROJECTS; PLEASURE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SET (PSYCHOLOGY); YOUNG ADULT;

EID: 77955061273     PISSN: 00315990     EISSN: 17446163     Source Type: Journal    
DOI: 10.1111/j.1744-6163.2010.00255.x     Document Type: Article

References (51)

1. Addington D, Addington J, Maticka-Tyndale E. Assessing depression in schizophrenia: The Calgary Depression Scale. British Journal of Psychiatry 1993, 22:39-44. Suppl
2. Addington D, Addington J, Maticka-Tyndale E. Specificity of the Calgary Depression Scale for schizophrenics. Schizophrenia Research 1994, 11(3):239-244.
3. Addington D, Addington J, Maticka-Tyndale E, Joyce J. Reliability and validity of a depression rating scale for schizophrenics. Schizophrenia Research 1992, 6(3):201-208.
4. Diagnostic and statistical manual of mental disorders 2000, American Psychiatric Association, 4th, ed., Text Revision, Washington, DC, Author
5. Andreasen N C. The Scale for the Assessment of Negative Symptoms (SANS): Conceptual and theoretical foundations. British Journal of Psychiatry 1989, 7:49-58. Suppl
6. Bengtsson-Tops A. Mastery in patients with schizophrenia living in the community: Relationship to sociodemographic and clinical characteristics, needs for care and support, and social network. Journal of Psychiatric Mental Health Nursing 2004, 11(3):298-304.
7. Berenbaum H, Oltmanns T F. Emotional experience and expression in schizophrenia and depression. Journal of Abnormal Psychology 1992, 101(1):37-44.
8. Blanchard J J, Horan W P, Brown S A. Diagnostic differences in social anhedonia: A longitudinal study of schizophrenia and major depressive disorder. Journal of Abnormal Psychology 2001, 110(3):363-371.
9. Blanchard J J, Mueser K T, Bellack A S. Anhedonia, positive and negative affect, and social functioning in schizophrenia. Schizophrenia Bulletin 1998, 24(3):413-424.
10. Chadwick P, Birchwood M, Trower P. Cognitive therapy for delusions, voices and paranoia 1996, Chichester, John Wiley & Sons, Ltd
11. Donohoe G, Robertson I H. Can specific deficits in executive functioning explain the negative symptoms of schizophrenia? A review. Neurocase 2003, 9(2):97-108.
12. Erhart S M, Marder S R, Carpenter W T. Treatment of schizophrenia negative symptoms: Future prospects. Schizophrenia Bulletin 2006, 32(2):234-237.
13. Favrod J, Ernst F, Giuliani F, Bonsack C. Validation of the Temporal Experience of Pleasure Scale (TEPS) in a French-speaking environment. Encephale 2009, 35(3):241-248.
14. Favrod J, Vianin P, Pomini V, Mast F W. A first step toward cognitive remediation of voices: A case study. Cognitive Behaviour Therapy 2006, 35(3):159-163.
15. Gard D E, Germans Gard M, Kring A M, John O P. Anticipatory and consummatory components of the experience of pleasure: A scale development study. Journal of Research in Personality 2006, 40:1086-1102.
16. Gard D E, Kring A M, Gard M G, Horan W P, Green M F. Anhedonia in schizophrenia: Distinctions between anticipatory and consummatory pleasure. Schizophrenia Research 2007, 93(1-3):253-260.
17. Germans M K, Kring A M. Hedonic deficit in anhedonia: Support for the role of approach motivation. Personality and Individual Differences 2000, 28(4):659-672.
18. Gold J M, Waltz J A, Prentice K J, Morris S E, Heerey E A. Reward processing in schizophrenia: A deficit in the representation of value. Schizophrenia Bulletin 2008, 34(5):835-847.
19. Harrow M, Grossman L S, Jobe T H, Herbener E S. Do patients with schizophrenia ever show periods of recovery? A 15-year multi-follow-up study. Schizophrenia Bulletin 2005, 31(3):723-734.
20. Harrow M, Herbener E S, Shanklin A, Jobe T H, Rattenbury F, Kaplan K J. Follow-up of psychotic outpatients: Dimensions of delusions and work functioning in schizophrenia. Schizophrenia Bulletin 2004, 30(1):147-161.
21. Heerey E A, Gold J M. Patients with schizophrenia demonstrate dissociation between affective experience and motivated behavior. Journal of Abnormal Psychology 2007, 116(2):268-278.
22. Heerey E A, Robinson B M, McMahon R P, Gold J M. Delay discounting in schizophrenia. Cognitive Neuropsychiatry 2007, 12(3):213-221.
23. Hellzén O, Kristiansen L, Norbergh K G. Living in a group dwelling: How do residents spend their time in a psychiatric group dwelling? International Journal of Nursing Studies 2004, 41(6):651-659.
24. Herbener E S, Harrow M. The course of anhedonia during 10 years of schizophrenic illness. Journal of Abnormal Psychology 2002, 111(2):237-248.
25. Herbener E S, Harrow M. Are negative symptoms associated with functioning deficits in both schizophrenia and nonschizophrenia patients? A 10-year longitudinal analysis. Schizophrenia Bulletin 2004, 30(4):813-825.
26. Herbener E S, Harrow M, Hill S K. Change in the relationship between anhedonia and functional deficits over a 20-year period in individuals with schizophrenia. Schizophrenia Research 2005, 75(1):97-105.
27. Horan W P, Green M F, Kring A M, Nuechterlein K H. Does anhedonia in schizophrenia reflect faulty memory for subjectively experienced emotions? Journal of Abnormal Psychology 2006, 115(3):496-508.
28. Jacobson N S, Truax P. Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology 1991, 59(1):12-19.
29. Jolley S, Garety P, Dunn G, White J, Aitken M, Challacombe F, Craig T. A pilot validation study of a new measure of activity in psychosis. Social Psychiatry and Psychiatric Epidemiology 2005, 40(11):905-911. doi: 10.1007/s00127-005-0982-x
30. Jolley S, Garety P A, Ellett L, Kuipers E, Freeman D, Bebbington P E, Dunn G. A validation of a new measure of activity in psychosis. Schizophrenia Research 2006, 85(1):288-295. doi: 10.1016/j.schres.2006.03.012
31. Kanter J. Clinical case management: Definition, principles, components. Hospital and Community Psychiatry 1989, 40(4):361-368.
32. Kim S W, Kim S J, Yoon B H, Kim J M, Shin I S, Hwang M Y, Yoon J S. Diagnostic validity of assessment scales for depression in patients with schizophrenia. Psychiatry Research 2006, 144(1):57-63. doi: 10.1016/j.psychres.2005.10.002
33. Kopelowicz A, Liberman R P, Zarate R. Recent advances in social skills training for schizophrenia. Schizophrenia Bulletin 2006, 32(1):S12-S23. Suppl
34. Kring A M. Emotion in schizophrenia: Old mystery, new understanding. Current Directions in Psychological Science 1999, 8:160-163.
35. Kring A M, Earnst K S. Stability of emotional responding in schizophrenia. Behavior Therapy 1999, 30:373-388.
36. Kring A M, Neale J M. Do schizophrenic patients show a disjunctive relationship among expressive, experiential, and psychophysiological components of emotion? Journal of Abnormal Psychology 1996, 105(2):249-257.
37. Lancon C, Auquier P, Reine G, Bernard D, Toumi M. Study of the concurrent validity of the Calgary Depression Scale for Schizophrenics (CDSS). Journal of Affective Disorders 2000, 58(2):107-115.
38. Lancon C, Auquier P, Reine G, Toumi M, Addington D. Evaluation of depression in schizophrenia: Psychometric properties of a French version of the Calgary Depression Scale. Psychiatry Research 1999, 89(2):123-132.
39. Lecrubier Y, Quintin P, Bouhassira M, Perrin E, Lancrenon S. The treatment of negative symptoms and deficit states of chronic schizophrenia: Olanzapine compared to amisulpride and placebo in a 6-month double-blind controlled clinical trial. Acta Psychiatrica Scandinavica 2006, 114(5):319-327.
40. Muller M J, Muller K M, Fellgiebel A. Detection of depression in acute schizophrenia: Sensitivity and specificity of 2 standard observer rating scales. Canadian Journal of Psychiatry 2006, 51(6):387-392.
41. Murphy B P, Chung Y C, Park T W, McGorry P D. Pharmacological treatment of primary negative symptoms in schizophrenia: A systematic review. Schizophrenia Research 2006, 88(1-3):5-25.
42. Norman R M, Malla A K, Cortese L, Diaz F. A study of the interrelationship between and comparative interrater reliability of the SAPS, SANS and PANSS. Schizophrenia Research 1996, 19(1):73-85.
43. Peralta V, Cuesta M J. Negative symptoms in schizophrenia: A confirmatory factor analysis of competing models. American Journal of Psychiatry 1995, 152(10):1450-1457.
44. Petersen L, Jeppesen P, Thorup A, Abel M B, Ohlenschlaeger J, Christensen T O, Nordentoft M. A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness. British Medical Journal 2005, 331(7517):602. doi: 10.1136/bmj.38565.415000.E01
45. Rector N A, Seeman M V, Segal Z V. Cognitive therapy for schizophrenia: A preliminary randomized controlled trial. Schizophrenia Research 2003, 63(1-2):1-11.
46. Sensky T, Turkington D, Kingdon D, Scott J L, Scott J, Siddle R, Barnes T R E. A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry 2000, 57(2):165-172.
47. Stahl S M, Buckley P F. Negative symptoms of schizophrenia: A problem that will not go away. Acta Psychiatrica Scandinavica 2007, 115(1):4-11.
48. Tarrier N. Cognitive behaviour therapy for schizophrenia-A review of development, evidence and implementation. Psychotherapy and Psychosomatics 2005, 74(3):136-144.
49. Thorup A, Petersen L, Jeppesen P, Ohlenschlaeger J, Christensen T, Krarup G, Nordentoft M. Integrated treatment ameliorates negative symptoms in first episode psychosis-Results from the Danish OPUS trial. Schizophrenia Research 2005, 79(1):95-105. doi: 10.1016/j.schres.2004.12.020
50. Winograd-Gurvich C, Fitzgerald P B, Georgiou-Karistianis N, Bradshaw J L, White O B. Negative symptoms: A review of schizophrenia, melancholic depression and Parkinson's disease. Brain Research Bulletin 2006, 70(4-6):312-321.
51. Zimmermann G, Favrod J, Trieu V H, Pomini V. The effect of cognitive behavioral treatment on the positive symptoms of schizophrenia spectrum disorders: A meta-analysis. Schizophrenia Research 2005, 77(1):1-9.